17 10, 2024 Andrea Boscolo Bragadin et al., Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer adlitterio663392024-10-17T11:21:01+02:00 Mehr erfahren
1 01, 2024 Andrea Boscolo Bragadin et al., Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patients adlitterio663392024-01-01T14:40:45+01:00 Mehr erfahren
